Sanofi-Aventis says that CFO Jean-Claude Leroy is quitting and will be replaced by deputy Laurence Debroux. The move comes just two weeks after Chris Viehbacher took the top post in the company.
Investors endorsed KV Pharmaceuticals' move to fire CEO Marc Hermelin last Friday, sending shares of the company up on Monday. Hermelin had been CEO since 1975.
Orexigen Chief Executive Officer Gary Tolefson stepped down as director and CEO, ending a previously announced leave of absence so he can focus on his recovery from a previously disclosed diagnosis of acute leukemia.
Dionex announced that Lukas Braunschweiler has notified the board of directors of his resignation as president and CEO.
ThermoGenesis says it has reached an agreement with CEO William Osgood for his immediate resignation.
NovaRx Corporation named Norrie J.W. Russell, Ph.D to the position of president and chief operating officer.
Hemispherx Biopharma, announced the appointment of new Chief Financial Officer (interim), Charles T. Bernhardt, C.P.A, M.B.A., effective January 1, 2009. Robert E. Peterson, Hemispherx's CFO for approximately 20 years, is retiring at that time.
SV Life Sciences has named three new venture partners. They are: Sarah Bodary, Ph.D., based in the San Francisco office; Gary Velasquez, based in the San Francisco office; and Kevin Barrett, based in the Boston office.
Microchip Biotechnologies announced that Ezra Van Gelder has joined its team as executive vice president of R&D.
Cortria Corporation has named Dennis H. Giesing, Ph.D., head of research and development.
Haemonetics announced that Dr. Jonathan White will join the company as head of research and development, vice president.
Microchip Biotechnologies named Ezra Van Gelder as executive vice president of R&D.
IDEXX Laboratories appointed William E. Brown, PhD as corporate vice president, instrument research and development and manufacturing.
GVK Biosciences Private Limited announced the appointment of Dr. Shoibal Mukherjee to the position of senior vice president-clinical development.
FibroGen announced the appointment of K. Peony Yu, M.D., as vice president, clinical development.
Interleukin Genetics named Todd Anthony Walker vice president, marketing.
Avila Therapeutics has named Daniel S. Lynch as executive chairman to Avila''s board of directors.
Momenta Pharmaceuticals has appointed James Sulat--a member of the board since June 2008--as its new chairman.
Delcath Systems has appointed Roger G. Stoll, Ph.D. to its board of directors.
Genomic Health has appointed Ginger Graham to its board.
Celera has elected Wayne Roe as its director.
Dana M. Fowlkes resigned his position as a member of the board of directors of Karo Bio.
PDL BioPharma has hired David Parkinson MD as a member of the board of Facet Biotech Corporation.